Taarnhøj, G A, Johansen, C, Carus, A, Dahlrot, R H, Dohn, L H, Lindberg, H & Pappot, H 2022, ' The iBLAD study: Patient-reported outcomes in bladder cancer during oncological treatment: A multicenter national randomized controlled trial ', Annals of Oncology, vol. 33, no. Suppl. 7, 1556MO, pp. S1259-S1260 . https://doi.org/10.1016/j.annonc.2022.07.1650
Trip, A K, Veluppillai, V K, Dahlrot, R H, Guldberg, T L, Muhic, A, Høyer, M & Lukacova, S 2021, ' TRENDS IN POSTOPERATIVE CHEMORADIOTHERAPY FOR GLIOBLASTOMA PATIENTS: A DANISH COHORT STUDY ', Neuro-Oncology, vol. 23, no. 2, pp. 51 . https://doi.org/10.1093/neuonc/noab180.176
Lorenzen, E L, Kallehauge, J F, Byskov, C S, Dahlrot, R H, Haslund, C A, Guldberg, T L, Lassen-Ramshad, Y, Lukacova, S, Muhic, A, Nystrom, P W, Haldbo-Classen, L, Bahij, I, Larsen, L, Weber, B & Hansen, C R 2021, ' A national study on the inter-observer variability in delineation of organs at risk in the brain ', Radiotherapy and Oncology, vol. 161, no. Suppl. 1, PH-0608, pp. S473-S475 . https://doi.org/10.1016/S0167-8140(21)07380-1
Knudsen, A M, Eilertsen, I, Kielland, S, Pedersen, M W, Sorensen, D, Dahlrot, R H, Boldt, H B, Mellegaard, C S, Munthe, S, Poulsen, F R & Kristensen, B W 2018, ' Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas ', Neuro-Oncology, vol. 20, no. Suppl. 3, pp. 284 . https://doi.org/10.1093/neuonc/noy139.259
Klitkou, J, Dahlrot, R H, Hansen, S & Kristensen, B W 2014, ' The biomarker potential of MGMT protein expression in glioblastoma is improved by exclusion of non-tumor cells ', Neuro-Oncology, vol. 16, no. 2 (Supplement), pp. ii40 . https://doi.org/10.1093/neuonc/nou174.148